Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Physical activity, height, and smoking affect prostate cancer risk.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

Selective breeding can enhance immunity in dairy cattle.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Cancer development is like natural selection, involving mutated cells and environmental factors.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Proteins from stem cells improved hair growth in patients with hair loss.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.